Three major 2026 infectious disease/antimicrobial stewardship trials, summarized in full CCR 11-part format — spanning a repurposed antiviral, rapid diagnostics, and device-associated infection prevention.
REMAP-CAP Ivermectin — Ivermectin for Hospitalized COVID-19FAST — Rapid Antimicrobial Susceptibility Testing for Gram-Negative BacteremiaCLiCK — 4% Tetrasodium EDTA for CVAD Complication Prevention🦠